INTRODUCTION
In mission Indians, an alcoholism severity phenotype has been mapped to chromosome 4 to a region containing a cluster of genes, coding for alcohol dehydrogenase peptide and alpha synuclein (1) . Results from this paper hint towards a possible involvement of a gene apart from the two neighboured alcohol dehydrogenase genes ADH1B and ADH1C. In addition several other linkage studies point to the same region (2 -4) . Furthermore, alpha synuclein maps to a quantitative trait locus for alcohol preference, and expression of alpha synuclein in different brain areas is increased in rats whose alcohol preference is inbred (5) . Most recently, evidence has been presented that alpha synuclein levels are elevated in midbrain dopamine neurons of chronic cocaine abusers (6) . Furthermore, an increased expression of alpha synuclein mRNA in patients with alcoholism has been observed, which correlates to craving in addicted patients with alcoholism (7) .
Alpha synuclein is involved in dopaminergic neurotransmission (8) . It regulates synaptic dopamine homeostasis (9) and influences the expression of dopamine synthesis genes such as GTP cyclohydrolase, TH and aromatic acid decarboxylase (10) . Dopaminergic transmission has been suggested to be a main mechanism mediating reinforcement, withdrawal and craving associated with alcohol addiction (11) . The dopamine-containing projection from the ventral tegmental area of the midbrain to the nucleus accumbens is critically involved in the mediation of seeking behaviour in addiction disorders (12) .
Alpha synuclein plays a major part in Parkinson's disease (8,13 -15) . Mounting evidence suggests an inverse association among cigarette smoking, alcohol drinking, coffee consumption and Parkinson's disease (16 -18) . Apart from the possibility of environmental risk factors, genetic susceptibility is discussed as a major factor. This may lead to speculation, which genes involved in Parkinson's disease might influence behaviour concerning substance abuse.
Several polymorphisms within NACP have been extensively analysed in patients suffering from Parkinson's disease. Especially for NACP-REP1, which is located 5 0 of the alpha synuclein promoter, various studies have shown importance for alpha synuclein expression (19 -21) . Its significance for Parkinson's disease is yet unclear with controversial findings in several studies (22) . However, the role of the repeat within intron 4 is not well understood. Therefore, the aim of this study was to investigate whether genetic polymorphisms, influencing the expression of alpha synuclein differ between patients with alcoholism compared with healthy controls.
RESULTS
A TC-rich repeat downstream of the exon 4/intron 4 boundary was described by Xia et al. (23) . Four different alleles ranging from 265 to 362 bp were identified in a Caucasian population whereby in different diseases such as Alzheimer's disease, Lewy-body disease or Parkinson's disease no correlation of repeat length and disease status was observed. In the present study, 70 patients and 89 controls (140 and 178 alleles, respectively) were analysed for the repeat in intron 4. As shown in Figure 1A , no significant differences between alcoholdependent patients and controls were observed (x 2 ¼ 7.0; df ¼ 3, P . 0.05). We also did not find a significant trend in this group so that a further increase in case/sample numbers did not seem to deliver any additional informations. Both groups showed allele frequencies comparable to the frequencies reported in control populations in previous studies (23) .
NACP-Rep1 is a polymorphic complex repeat site located 10 kb upstream of the translational start of NACP. The repeat is highly interesting because several association studies have demonstrated a link between certain alleles and an increased risk of sporadic Parkinson's disease in different populations. The significance of these observations is underlined by findings describing an increased expression of alpha synuclein depending on the allele length (20) . Figure 1B illustrates the distribution of alleles within NACP-REP1 in our sample: in total, 135 patients and 101 controls were investigated (270 and 202 alleles, respectively). Astonishingly, alcoholic patients show completely different frequencies compared with healthy controls with highly significant expanded alleles (x 2 ¼ 99.5; df ¼ 3, P , 0.001). Controls show a maximum at allele 269 (60%), whereas patients with alcoholism show a maximum at allele 271 (50%). The most significant difference in allele distribution is found for the two longest alleles 271 and 273 as well as the shortest allele 267.
It was further analysed whether these findings on the genomic level also have an effect on alpha synuclein expression. Alpha synuclein mRNA was quantified and mRNA levels were correlated with the allele lengths: the allele lengths of NACP-REP1 correlate with levels of alpha synuclein mRNA whereby the repeat lengths are significantly associated with higher alpha synuclein mRNA expression (Kruskal -Wallis test, x 2 ¼ 8.83; df ¼ 2, P ¼ 0.012) (Fig. 2) . The estimated differences and simultaneous confidence intervals of levels of alpha synuclein indicate that the global difference stems from a large effect between long and short allele lengths (estimated difference 1.189 with 90% confidence interval of 0.126 -2.251), whereas no effect between intermediate and short (0.434; 20.349 to 1.218) and long and intermediate allele lengths (0.755; 20.181 to 1.690) can be established.
This indicates that the regulative role of NACP-REP1 is not only restricted to cell culture systems but also can be demonstrated in human blood cells.
DISCUSSION
To our knowledge, this is the first study evaluating repeats within the NACP gene in patients with alcoholism. Allele frequencies between controls and patients did not reveal any 
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differences for the repeat in intron 4, but highly significant longer alleles of NACP-REP1 were found in alcoholics compared with healthy controls. The allelic frequencies within the controls are in line with former findings and show the same frequencies as have been published in several other earlier studies (20, 22) . Whether NACP-REP1 affects alpha synuclein levels in long-term abstinent patients remains to be resolved in future studies.
As it has been shown in previous studies (19 -21) , the length of NACP-REP1 influences the expression of alpha synuclein. It has been shown that there is a considerable variability in alleles of the same length (24) which might confound conventional genotype association analysis. Therefore, further investigations must clarify the influence of variability within alleles of the same length with respect to alpha synuclein expression levels. However, this latter effect was clearly shown in alleles with different lengths (19 -21) . Moreover, it has been shown that the expression of alpha synuclein is elevated in patients with alcoholism whereby higher mRNA alpha synuclein levels were significantly linked to alcohol craving (7). Most recently, it has been shown that SNCA triplication results in a doubling in the amount of alpha synuclein protein in blood which possibly demonstrates a correlation between peripheral and central expressions (25) . This is further in line with our preliminary results showing that protein concentrations in blood correlate to alpha synuclein mRNA levels in patients with alcoholism (data not shown). The results of the present study are in accordance with previous studies linking alpha synuclein levels, which promote neuronal dopamine release, to cocaine (6) and alcohol seeking behaviour (5) . Dopaminergic transmission has been suggested to be a main mechanism mediating reinforcement, withdrawal and craving associated with alcohol addiction (11) . In addition, the present findings are consistent with the observation of an altered mRNA expression of alpha synuclein in frontal and motor cortices of human alcoholics (26) .
The present study provides first evidence for a linkage of higher levels of synuclein and genetic distribution of alleles within NACP-REP1 in patients with alcoholism. This hints towards a novel pathophysiologic mechanism in alcoholism. Longer alleles of NACP-REP1 lead to a higher expression of alpha synuclein which is associated with alcohol craving, an important factor for development, maintenance and relapse of alcoholism. Further studies will help to elucidate the possible role of polymorphisms within NACP as well as the function of alpha synuclein in the pathophysiology of addictive disorders.
MATERIALS AND METHODS

Subjects
The present prospective case -control study was approved by the Institutional Review Board of the University of ErlangenNuremberg. All southern (franconian) German subjects had been informed and had signed a consent form before participating in any part of the study. Caucasian controls (mean age 44.3, SD 11.2; range 20-72) were matched to Caucasian patients by age and smoking. Only males were included into both groups because of the small sample size of females. The male healthy controls had no disorder meeting Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria, and alcohol consumption did not exceed 30 g ethanol intake per week. Two experienced psychiatrists (D.B. and U.R.) independently examined all healthy subjects who were recruited from the Department of Ophthalmology (University of Erlangen-Nuremberg). Study characteristics of both patients and controls, such as sociodemographic data, period of alcohol consumption, last alcohol intake, daily intake of alcohol, estimation of lifetime drinking, smoking behaviour or medical history, were taken using a modified semi-structured interview (7, 27 ) (data not shown). All male patients (mean age 43.8, SD 9.2; range 24-65) from the Franconian Alcoholism Research Studies (FARS) (28) were active drinkers or had abstained from alcohol between 24 and 72 h (early abstinence). Each of them had an established diagnosis of alcohol dependence according to DSM-IV with a history of alcohol consumption ranging from 7 to 42 years (mean 18.9 years, SD 10.0). Patients with any other concomitant psychiatric illness were excluded from the study. Furthermore, patients with any commonly known risk factors affecting alpha synuclein (i.e. Alzheimer's disease, Parkinson's disease, pesticides, particularly the herbicide paraquat or abnormal copper homoeostasis) were not enrolled.
Genetic and laboratory analyses
Fasting blood samples for DNA extraction were drawn on admission in ethylenediaminetetraacetic (EDTA) acidcontaining tubes and were stored at 2808C immediately after collection. A Y-STR core set of DYS 19 The regions of the NACP gene containing the repeat polymorphisms were amplified by PCR using the following primers: REP1 (CCT GGC ATA TTT GAT TGC AA) and REP2 (GAC TGG CCC AAG ATT AAC CA) according to Xia et al. (29) ; Intron4-F (CCT CTG GTA TTC CCA GTC TC) and Intron4-R (CAC ATT ATG TAT TAT ATT TAA AGG TG) (23) with both reverse primers being 5 0 -fluorescently labelled with TAMRA. PCR was performed according standard procedures and products were analysed on an ABI-sequencer (ABI 320) together with a ROX-labelled size standard (Amersham) and scored by GeneScan (version 2.0).
Total RNA was extracted from whole frozen EDTA-blood using a modified Qiagen-protocol: a phenol-extraction in Qiazol (Qiagen) was followed by column-purification with RNAeasy Mini Kit (Qiagen) including DNase digestion. Reverse transcription was performed by using poly-dT primers and AMV Reverse Transcriptase from the Roche cDNA Synthesis System. Quantitative PCR was performed using SYBR Green I Master Mix buffer (Applied Biosystems), and reactions were run on an iCycler (BioRad) using a threestep standard protocol with an annealing temperature of 668C. GAPDH was used as internal standard, and DCT values were calculated from differences between GAPDH and alpha synuclein. All experiments were repeated three times. We used the following primer pairs: GAPDH-F (CACCAGGGCTGCTTT TAACTCTGGTA) and GAPDH-R (CCTTGACGGTGCCATG GAATTTGC); A-Syn-F (GCCAAGGAGGG-AGTTGTGGCT GC) and A-Syn-R (CTGTTGCCACACCATGCACCACTCC).
Statistical analyses
Distributions of all utilized variables were tested using Kolmogorov -Smirnov. As none of the variables was normally distributed, statistical analysis was done by non-parametric methods such as correlation analysis by Spearman, Chi-squared statistic and Kruskal -Wallis test. Sum scores were built from additive dinucleotide repeat lengths: the shortest repeat 267 was assigned to the numeric value of 0 points (repeat 269: two points, repeat 271: four points and repeat 273: six points). Both alleles were totalised. Therefore, a possible sum score between 0 and 12 points could be obtained. Afterwards, the sum scores were coded into three groups: short, 0 - Simultaneous Tukey all-pair confidence intervals for differences were used to assess the effect size and variability of alpha synuclein levels between groups of allele lengths. In addition, we performed logistic regression models to confirm the findings and to evaluate possible confounding factors. All statistical tests were two-sided and a significance level of a ¼ 0.05. Data were analysed using SPSS TM for Windows 12 (SPSS Inc., Chicago, IL, USA), confidence intervals were computed using the multcomp add-on package (30) within the R system (31) for statistical computing (version 2.0.1).
